|
January 22, 2025
|
Northwest Pharmacists Association CE Program Announcement January 22nd 7pm
|
|
November 20, 2024
|
Treatment of elevated lipoprotein (a) Lp(a), a cardiovascular risk factor
|
|
October 23, 2024
|
Northwest Pharmacists Association Live CE Event 10/23
|
|
September 18, 2024
|
Northwest Pharmacists CE Event - Hepatitis C
|
|
August 14, 2024
|
The Proof Is In The Pounds - Weight Loss Medications
|
|
June 17, 2024
|
CE Program: Effective Communication with Persons with Severe Persistent Mental Illness in the Pharmacy Setting.
|
|
May 29, 2024
|
Going for the GOLD. A Review of COPD
|
|
April 24, 2024
|
Northwest Pharmacists Assn. CE Program: Managing Metabolic Steatohepatitis
|
|
March 20, 2024
|
Northwest Pharmacists CE - Antiretroviral Therapy for HIV
|
|
February 21, 2024
|
Northwest Pharmacists Association CE Meeting - Anemia of Chronic Kidney Disease
|
|
January 24, 2024
|
Northwest Pharmacists Association CE Program 1/24 - Updates in Osteoporosis Management
|
|
November 15, 2023
|
Northwest Pharmacists Association Zoom Meeting November 15th @ 7pm“Don’t Sleep on This: Key Considerations in the Management of Sleep Disorders”
|
|
October 25, 2023
|
Updates to the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guidelines for the Management of Patients with Chronic Coronary Disease
|
|
September 20, 2023
|
The Tide is Turning: Genitourinary Complications
|
|
August 23, 2023
|
Hit Me With Your Best Shot: Vaccinations Update
|
|
May 24, 2023
|
“The 101 on GLP-1s: Updates on the use of GLP-1 agonists and analogues”
|
|
April 26, 2023
|
A Review of Recent Outpatient Pharmacist Expansion
|
|
March 22, 2023
|
Pharmacotherapy for Parkinson’s Disease
|
|
March 22, 2023
|
(copy) Pharmacotherapy for Parkinson’s Disease
|
|
February 22, 2023
|
Statin Substitutes: The Guide to Alternative Hyperlipidemia Medications
|
|
January 25, 2023
|
CE Sample
|